Weekly digest breakthroughs in cancer treatment, chemistry, and more by The Babak Lab
Maria Babak shared a post by The Babak Lab, on LinkedIn adding:
“Let’s recap on groundbreaking advancements in cancer treatment and chemistry, showing how innovation is pushing boundaries in both fields shared by The Babak Lab this week.
If you’re interested in how science is driving real change, especially in critical areas like healthcare and elemental research, you’ll want to check this out. It’s a compelling read for anyone curious about the future of science and medicine!”
Quoting The Babak Lab’s post:
“Weekly Digest Breakthroughs in Cancer Treatment, Chemistry, and More!
This week’s highlights from The Babak Lab bring you cutting-edge developments in cancer treatment, chemistry, and inspiring insights on making cancer a curable disease. Here’s why you can’t miss out:
The FDA’s accelerated approval of Adagrasib offers a promising new treatment for non-small cell lung cancer with the KRAS G12C mutation. Discover how this targeted therapy could change the lives of patients in historically challenging areas of treatment.
Berkeley Lab’s successful production of Livermorium (Element 116) using a 50Ti beam marks a new frontier in superheavy element research. This discovery opens doors to further exploration of the periodic table’s unknown territories.
The latest edition of Babak Monthly shares breakthroughs like the Crystalline Hydrogen Peroxide Complex and an exclusive interview with Vanessa Barrs. Stay informed and connected with the latest innovations from The Babak Lab.
Learn about the ongoing efforts to transform cancer from a deadly disease into a chronic, manageable condition. Discover how advancements in research, support for young scientists, and accessible care are paving the way toward a cancer-free future.
Stay ahead of the curve with the latest scientific breakthroughs that could reshape the future of healthcare and chemistry. Whether you’re passionate about medical innovation, scientific discovery, or supporting the fight against cancer, these updates will keep you informed and inspired.
Follow us for more insights and join the conversation on these groundbreaking developments!”
Source: Maria Babak/LinkedIn and The Babak Lab/LinkedIn
Dr. Maria (Masha) Babak is the Head of The Babak Lab and an Assistant Professor at the City University of Hong Kong. In November 2020, she joined the City University of Hong Kong as an assistant professor. Dr. Babak received the Graeme Hanson-AsBIC Early Career Award in 2022.
Her research interests are at the intersection of chemistry, biology, and medicine, with a focus on the discovery and preclinical development of anticancer drugs for resistant and aggressive cancers with limited treatment options, such as malignant pleural mesothelioma and brain metastases.